Spain · Delayed Price · Currency is EUR BME:PRS Statistics
Total Valuation
BME:PRS has a market cap or net worth of EUR 404.55 million. The enterprise value is 1.17 billion.
| Market Cap | 404.55M |
| Enterprise Value | 1.17B |
Important Dates
The next estimated earnings date is Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:PRS has 134.85 million shares outstanding. The number of shares has increased by 4.03% in one year.
| Current Share Class | 134.85M |
| Shares Outstanding | 134.85M |
| Shares Change (YoY) | +4.03% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 8.82% |
| Owned by Institutions (%) | 8.75% |
| Float | 41.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 96.77 |
| PS Ratio | 0.40 |
| PB Ratio | -1.15 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 2.87 |
| P/OCF Ratio | 2.71 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.38, with an EV/FCF ratio of 8.28.
| EV / Earnings | n/a |
| EV / Sales | 1.16 |
| EV / EBITDA | 6.38 |
| EV / EBIT | 9.50 |
| EV / FCF | 8.28 |
Financial Position
The company has a current ratio of 1.33
| Current Ratio | 1.33 |
| Quick Ratio | 1.20 |
| Debt / Equity | n/a |
| Debt / EBITDA | 4.84 |
| Debt / FCF | 6.28 |
| Interest Coverage | 1.75 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 9.09% |
| Return on Invested Capital (ROIC) | -8.45% |
| Return on Capital Employed (ROCE) | 23.57% |
| Weighted Average Cost of Capital (WACC) | 0.74% |
| Revenue Per Employee | 134,644 |
| Profits Per Employee | -1,823 |
| Employee Count | 7,476 |
| Asset Turnover | 1.19 |
| Inventory Turnover | 10.02 |
Taxes
In the past 12 months, BME:PRS has paid 44.02 million in taxes.
| Income Tax | 44.02M |
| Effective Tax Rate | 135.84% |
Stock Price Statistics
The stock price has decreased by -12.54% in the last 52 weeks. The beta is 0.79, so BME:PRS's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | -12.54% |
| 50-Day Moving Average | 2.98 |
| 200-Day Moving Average | 3.28 |
| Relative Strength Index (RSI) | 53.18 |
| Average Volume (20 Days) | 12,020 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:PRS had revenue of EUR 1.01 billion and -13.63 million in losses. Loss per share was -0.09.
| Revenue | 1.01B |
| Gross Profit | 513.25M |
| Operating Income | 122.96M |
| Pretax Income | 32.41M |
| Net Income | -13.63M |
| EBITDA | 159.04M |
| EBIT | 122.96M |
| Loss Per Share | -0.09 |
Balance Sheet
The company has 142.09 million in cash and 885.54 million in debt, with a net cash position of -743.45 million or -5.51 per share.
| Cash & Cash Equivalents | 142.09M |
| Total Debt | 885.54M |
| Net Cash | -743.45M |
| Net Cash Per Share | -5.51 |
| Equity (Book Value) | -353.01M |
| Book Value Per Share | -2.76 |
| Working Capital | 118.14M |
Cash Flow
In the last 12 months, operating cash flow was 149.51 million and capital expenditures -8.50 million, giving a free cash flow of 141.01 million.
| Operating Cash Flow | 149.51M |
| Capital Expenditures | -8.50M |
| Depreciation & Amortization | 36.08M |
| Net Borrowing | -35.32M |
| Free Cash Flow | 141.01M |
| FCF Per Share | 1.05 |
Margins
Gross margin is 50.99%, with operating and profit margins of 12.22% and -1.35%.
| Gross Margin | 50.99% |
| Operating Margin | 12.22% |
| Pretax Margin | 3.22% |
| Profit Margin | -1.35% |
| EBITDA Margin | 15.80% |
| EBIT Margin | 12.22% |
| FCF Margin | 14.01% |
Dividends & Yields
BME:PRS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.03% |
| Shareholder Yield | -4.03% |
| Earnings Yield | -3.37% |
| FCF Yield | 34.86% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for BME:PRS is 4.22, which is 43.05% higher than the current price. The consensus rating is "Hold".
| Price Target | 4.22 |
| Price Target Difference | 43.05% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 5.02% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on July 10, 2026. It was a reverse split with a ratio of 0.1.
| Last Split Date | Jul 10, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
BME:PRS has an Altman Z-Score of 1.05 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.05 |
| Piotroski F-Score | 5 |